Literature DB >> 16536810

Comparison of cryotherapy and curettage for the treatment of pyogenic granuloma: a randomized trial.

S Z Ghodsi1, M Raziei, A Taheri, M Karami, P Mansoori, F Farnaghi.   

Abstract

BACKGROUND: Pyogenic granuloma is a benign vascular lesion of the skin and mucous membranes. Many different treatments have been used, with variable success rates.
OBJECTIVES: To evaluate and compare the effects of cryotherapy and curettage in the treatment of pyogenic granuloma.
METHODS: Eighty-nine patients with pyogenic granuloma were randomized to receive cryotherapy with liquid nitrogen or curettage and electrodesiccation. Forty patients in the cryotherapy group and 36 patients in the curettage group completed the study period.
RESULTS: Among the patients who completed the study, treatment resulted in complete resolution of all lesions after one to three sessions (mean 1.42) in the cryotherapy group and after one to two sessions (mean 1.03) in the curettage group. The difference between the two groups was statistically significant (P < 0.001). Twenty-three patients (57.5%) in the cryotherapy group and 25 patients (69%) in the curettage group had no scar or pigmentation abnormality. Except for cosmetic problems, no other side-effect or complication was recorded in the study.
CONCLUSIONS: This study showed that both cryotherapy and curettage are safe and effective. Curettage had the advantage of fewer treatment sessions required to achieve resolution and better cosmetic results. We suggest that curettage could be the first-line treatment for pyogenic granuloma.

Entities:  

Mesh:

Year:  2006        PMID: 16536810     DOI: 10.1111/j.1365-2133.2005.06923.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors:  Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

Review 2.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

3.  Clinical case of botryomycome fulminant at the center of diagnostic and treatment of tuberculosis of Baleng (West - Cameroon).

Authors:  Michel Noubom; Bruno Kenfack; Jean Hubert Donfack; Fabrice Djouma Nembot; Zacharie Sando
Journal:  Pan Afr Med J       Date:  2013-04-04

Review 4.  Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors.

Authors:  I Lupu; V M Voiculescu; N Bacalbasa; B E Prie; I Cojocaru; C Giurcaneanu
Journal:  J Med Life       Date:  2015

5.  Pyogenic granuloma in relation to dental implants: Clinical and histopathological findings.

Authors:  Eduardo Anitua; Laura Pinas
Journal:  J Clin Exp Dent       Date:  2015-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.